产品编号 :
Cas No. :
CAS No. |
252025-52-8 |
|---|---|
英文名称 |
1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide |
别名 |
1-(2,4-dichlorobenzyl)indazole-3-carbohydrazide;CS-2018;AF-2364;1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide;Adjudin, AF-2364;Adjudin;1-[(2,4-Dichlorophenyl)methyl]-1H-indazole-3-carboxylic acid hydrazide;1-(2,4-Dichloro-benzyl)-1H-indazole-3-carboxylic acid hydrazide |
标准英文名 |
1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide |
分子式 |
C15H12Cl2N4O |
分子量 |
335.19 |
精确分子量 |
334.04 |
SMILES |
NNC(=O)C1=NN(CC2=CC=C(Cl)C=C2Cl)C2=C1C=CC=C2 |
标准SMILES |
NNC(=O)C1=NN(CC2=CC=C(Cl)C=C2Cl)C2C=CC=CC=21 |
用途 |
Adjudin (AF-2364) is a potential male oral contraceptive that induces reversible male infertility by disrupting adherens junctions between Sertoli and germ cells in the testes, leading to premature release of spermatids; it also acts as a potent blocker of Cl⁻ channels, thereby impairing human sperm capacitation and fertilizing ability in vitro; additionally, Adjudin exhibits anti-inflammatory properties by inhibiting NF-κB p65 nuclear translocation, DNA binding activity, and ERK MAPK phosphorylation; it demonstrates anticancer activity by inhibiting proliferation of various human and mouse cancer cell lines (including gastric, breast, liver, pancreatic, lung, and prostate cancer cells) in a dose-dependent manner; in vivo studies show that Adjudin significantly suppresses tumor growth in xenograft models of human lung (A549) and prostate (PC3) cancers. |
InChIKey |
VENCPJAAXKBIJD-UHFFFAOYSA-N |
|
|
评论 |
|---|